clinical trial · NCT06247839
The Effects of Psilocybin on Self-Focus and Self-Related Processing in Major Depressive Disorder
Sharmin Ghaznavi·phase3·recruiting·n = 20
Major Depressive DisorderPsilocybin
brief summary
This open-label functional Magnetic Resonance Imaging (fMRI) study will assess the effects of a single dose of psilocybin on rumination and the neural correlates of rumination in individuals with major depressive disorder.
started
Sep 10, 2024
primary completion
Jun 30, 2028
completion
Jun 30, 2028
last updated
Jul 17, 2026
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol